Matthias Bodenstedt
2021
In 2021, Matthias Bodenstedt earned a total compensation of $764.2K as Chief Financial Officer at MoonLake Immunotherapeutics.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $4,691 |
|---|---|
| Salary | $162,454 |
| Stock Awards | $597,068 |
| Total | $764,213 |
Bodenstedt received $597.1K in stock awards, accounting for 78% of the total pay in 2021.
Bodenstedt also received $4.7K of change in pension value and nonqualified deferred compensation earnings and $162.5K in salary.
Rankings
In 2021, Matthias Bodenstedt's compensation ranked 9,632nd out of 12,415 executives tracked by ExecPay. In other words, Bodenstedt earned more than 22.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,632 out of 12,415 | 22nd |
Division Manufacturing | 4,268 out of 5,505 | 23rd |
Major group Chemicals And Allied Products | 1,889 out of 2,375 | 21st |
Industry group Drugs | 1,676 out of 2,096 | 20th |
Industry Pharmaceutical Preparations | 1,247 out of 1,546 | 19th |
Source: SEC filing on April 26, 2023.
Bodenstedt's colleagues
We found two more compensation records of executives who worked with Matthias Bodenstedt at MoonLake Immunotherapeutics in 2021.